Skip to main content

Advertisement

Log in

Importance of patient, tumour and treatment related factors on quality of life in head and neck cancer patients after definitive treatment

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

The purpose of this study is to assess patient, tumour and treatment related factors on quality of life (QoL) outcomes of patients who received definitive or postoperative radiotherapy ± chemotherapy for head and neck (H&N) cancer. In this cross-sectional study, 110 H&N cancer patients were evaluated in follow-up visit and were asked to fill out the European Organisation for Research and Treatment of Cancer QoL Core Questionnaire (QLQ-C-30) and H&N Module (QLQ-H&N35). Patients were also graded for their late side effects using EORTC/RTOG scoring system. The QLQ C-30 and QLQ-H&N35 mean scores were compared using ANOVA analysis for these variables: age, gender, occupation, educational status, social security status, place of residence, tumour localization, clinical stage, comorbidity, Karnofsky performance score, treatment modality and side effects. Median follow-up was 29 (4–155) months. Tumour localization was significant factor affecting physical (P = 0.03), social (P = 0.01), cognitive (P = 0.002) functioning. Treatment modality had significant impact on the physical (P = 0.02) and cognitive scores (P = 0.008). Global QoL was affected significantly by disease stage (P = 0.01) and occupation (P = 0.01). The QLQ-H&N35 scores were found significantly higher in patients with moderate/severe late morbidity. Tumour localization and the treatment modality are the most important factors affecting the QoL of H&N cancer patients treated definitively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. International agency for Research on Cancer webpage, Cancer Mondial. Available via http://www-dep.iarc.fr

  2. Hall SF, Groome PA, Rothwell D (2000) The impact of comorbidity on the survival of patients with squamous cell carcinoma of the head and neck. Head Neck 22(4):317–322. doi:10.1002/1097-0347(200007)22:4<317::AID-HED1>3.0.CO;2-0

    Article  PubMed  CAS  Google Scholar 

  3. Sturgis EM, Wei Q, Spitz MR (2004) Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol 31(6):726–733. doi:10.1053/j.seminoncol.2004.09.013

    Article  PubMed  Google Scholar 

  4. Lefebvre JL (2005) Current clinical outcomes demand new treatment options for SCCHN. Ann Oncol 16(Suppl 6):vi7–vi12. doi:10.1093/annonc/mdi452

    Article  PubMed  Google Scholar 

  5. Lawrence TS, Blackstock AW, McGinn C (2003) The mechanism of action of radiosensitization of conventional chemotherapeutic agents. Semin Radiat Oncol 13:13–21. doi:10.1053/srao.2003.50002

    Article  PubMed  Google Scholar 

  6. Gotay CC (1996) Trial-related quality of life: using quality of life assessment to distinguish among cancer therapies. J Natl Cancer Inst Monogr 20:1–6

    PubMed  Google Scholar 

  7. Bjordal K, Ahlner-Elmqvist M, Tollesson E et al (1994) Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. Acta Oncol 33(8):879–885. doi:10.3109/02841869409098450

    Article  PubMed  CAS  Google Scholar 

  8. Bjordal K, Hammerlid E, Ahlner-Elmqvist M et al (1999) Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 17(3):1008–1019

    PubMed  CAS  Google Scholar 

  9. Hammerlid E, Bjordal K, Ahlner-Elmqvist M et al (2001) A prospective study of quality of life in head and neck cancer patients. Part I: at diagnosis. Laryngoscope 111(4 Pt 1):669–680. doi:10.1097/00005537-200104000-00021

    Article  PubMed  CAS  Google Scholar 

  10. Zackrisson B, Mercke C, Strander H et al (2003) A systematic overview of radiation therapy effects in head and neck cancer. Acta Oncol 42(5–6):443–461. doi:10.1080/02841860310014886

    Article  PubMed  Google Scholar 

  11. Bjordal K, de Graeff A, Fayers PM, et al (2000) A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer 36(14):1796–1807

    Google Scholar 

  12. Hanna E, Sherman A, Cash D et al (2004) Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg 130(7):875–879. doi:10.1001/archotol.130.7.875

    Article  PubMed  Google Scholar 

  13. Cengiz M, Ozyar E, Esassolak M et al (2005) Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules. Int J Radiat Oncol Biol Phys 63(5):1347–1353. doi:10.1016/j.ijrobp.2005.05.057

    Article  PubMed  Google Scholar 

  14. Huguenin PU, Taussky D, Moe K et al (1999) Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy: the importance of the target volume. Int J Radiat Oncol Biol Phys 45(1):47–52. doi:10.1016/S0360-3016(99)00128-5

    PubMed  CAS  Google Scholar 

  15. Tschudi D, Stoeckli S, Schmid S (2003) Quality of life after different treatment modalities for carcinoma of the oropharynx. Laryngoscope 113(11):1949–1954. doi:10.1097/00005537-200311000-00018

    Article  PubMed  Google Scholar 

  16. Singer S, Wollbrück D, Wulke C et al (2008) Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery. Head Neck 28 Oct (available online)

  17. Bansal M, Mohanti BK, Shah N et al (2004) Radiation related morbidities and their impact on quality of life in head and neck cancer patients receiving radical radiotherapy. Qual Life Res 13(2):481–488. doi:10.1023/B:QURE.0000018491.80646.bc

    Article  PubMed  CAS  Google Scholar 

  18. Jensen K, Bonde Jensen A, Grau C (2006) The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and The EORTC quality of life questionnaires. Radiother Oncol 78(3):298–305. doi:10.1016/j.radonc.2006.02.005

    Article  PubMed  Google Scholar 

  19. Machtay M, Moughan J, Trotti A et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26(21):3582–3589. doi:10.1200/JCO.2007.14.8841

    Article  PubMed  CAS  Google Scholar 

  20. Trotti A, Pajak TF, Gwede CK et al (2007) TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol 8(7):613–624. doi:10.1016/S1470-2045(07)70144-4

    Article  PubMed  Google Scholar 

  21. Arraras Urdaniz JI, Arias de la Vega F, Manterola Burgaleta A et al (2005) Quality of life in patients with locally advanced head and neck cancer treated with chemoradiotherapy. Comparison of two protocols using the EORTC questionnaires (QLQ-C30, H and N35). Clin Transl Oncol 7(9):398–403. doi:10.1007/BF02716585

    Article  PubMed  Google Scholar 

  22. Sherman AC, Simonton S, Adams DC et al (2000) Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35). Arch Otolaryngol Head Neck Surg 126(4):459–467

    PubMed  CAS  Google Scholar 

  23. Abendstein H, Nordgren M, Boysen M et al (2005) Quality of life and head and neck cancer: a 5-year prospective study. Laryngoscope 115(12):2183–2192. doi:10.1097/01.MLG.0000181507.69620.14

    Article  PubMed  Google Scholar 

  24. De Graeff A, De Leeuw JR, Ros WJ et al (2000) Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck 22(4):398–407. doi:10.1002/1097-0347(200007)22:4<;398::AID-HED14>;3.0.CO;2-V

    Article  PubMed  Google Scholar 

  25. Nordgren M, Jannert M, Boysen M et al (2006) Health-related quality of life in patients with pharyngeal carcinoma: a five-year follow-up. Head Neck 28(4):339–349. doi:10.1002/hed.20334

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zumre Arican Alicikus.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alicikus, Z.A., Akman, F., Ataman, O.U. et al. Importance of patient, tumour and treatment related factors on quality of life in head and neck cancer patients after definitive treatment. Eur Arch Otorhinolaryngol 266, 1461–1468 (2009). https://doi.org/10.1007/s00405-008-0889-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-008-0889-0

Keywords

Navigation